Medicinal cannabis: Why more clinical trials and better access is needed
Drug Discovery World
FEBRUARY 1, 2023
Michael Sassano , CEO at SOMAÍ Pharmaceuticals looks at what’s needed throughout Europe to help increase access to medicinal cannabis and the current state of pharmaceutical research in this area. However, the potential use of cannabis in a pharmaceutical setting is vast. The GW Pharmaceuticals purchase by Jazz for $6.7
Let's personalize your content